Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 13, 2010 12:35 ET | Source: Rexahn Pharmaceuticals, Inc.

Rexahn Pharmaceuticals Announces Phase IIa Study Results of Serdaxin in Major Depressive Disorder (MDD)

NEW YORK, April 13, 2010 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE Amex:RNN), a clinical stage pharmaceutical company developing potential best in class oncology and central nervous...
April 12, 2010 08:30 ET | Source: Rexahn Pharmaceuticals, Inc.

Update: Rexahn Pharmaceuticals to Present at Nasdaq Marketsite

Media and Investors Invited to the MarketSite, Times Square Tuesday, April 13, 2010, 12:15pm EDT, Others Invited to Video Webcast ROCKVILLE, Md., April 12, 2010 (GLOBE NEWSWIRE) -- Rexahn...